Office based screening of sperm autoimmunity

Area of Science:

• Reproductive Immunology
• Andrology
• Clinical Diagnostics

Background:

• Sperm autoimmunity is a significant factor in male infertility, affecting up to 10% of subfertile men.
• Current diagnostic methods like the direct immunobead test are complex and not ideal for routine screening.
• Accurate and accessible diagnostic tools are needed for early identification of antisperm antibodies.

Purpose of the Study:

• To introduce and evaluate a novel, office-based procedure, the sperm mixed antiglobulin reaction (SMAR), for detecting antisperm antibodies.
• To compare the diagnostic accuracy of SMAR with the established direct immunobead test (DIBT).
• To assess the utility of SMAR as a screening tool for male factor infertility.

Main Methods:

• A comparative diagnostic accuracy study was conducted on 102 semen specimens from men with male factor infertility.
• Both the sperm mixed antiglobulin reaction (SMAR) and the direct immunobead test (DIBT) were performed simultaneously on each specimen.
• Diagnostic performance metrics including sensitivity, specificity, positive predictive value, and negative predictive value were calculated.

Main Results:

• The sperm mixed antiglobulin reaction detected sperm autoantibodies in 19.6% of cases, compared to 16.6% for the direct immunobead test.
• SMAR demonstrated high diagnostic accuracy, with a sensitivity of 100% and specificity of 96% when compared to DIBT.
• The positive predictive value was 85%, and the negative predictive value was 100%, indicating SMAR's reliability.

Conclusions:

• The sperm mixed antiglobulin reaction is a highly sensitive and specific method for detecting antisperm antibodies.
• Its simplicity and accuracy make it an excellent screening tool for office-based evaluation of male fertility potential.
• SMAR can aid in the early and efficient diagnosis of sperm autoimmunity contributing to male infertility.